Keynote Speakers
Mr. Thomas Lönngren, Executive Director, EMEA, EU
Dr. Murray Lumpkin, Deputy Commissioner for International and Special Programs, US FDA, USA
Mr. Kazuhiko Mori, Associate Centre Director, Centre for Product Evaluation, PMDA, Japan
Dr. Lembit Rägo, Coordinator, Quality Assurance and Safety: Medicines, Medicines Policy and Standards, WHO, Switzerland
Dr. Budiono Santoso, Regional Advisor on Pharmaceuticals, WHO, WPRO, Philippines
Prof. Stuart Walker, CMR International Institute for Regulatory Science, UK
Dr. Stephen D. Wise, Director and Associate Professor of National University of Singapore, Lilly-NUS Centre for Clinical Pharmacology, Singapore
Official Programme
The Official Programme of the conference is now available.
Download it now! (1.19 MB)
Programme Changes
Please note that due to the new session on Pharmaceutical Industry Self Regulation and Business Ethics: Global and Regional Challenges, the conference will now end at 15h10 (3h10PM) on Thursday, March 13th, 2008. Check the new programme for more info >>
A Conference to:
- Strengthen cooperation between Asian Regulatory Authorities and Pharmaceutical Industry
- Facilitate discussion on common issues in the regulatory and technical areas in the Asia Pacific region
- Encourage greater harmonization of regulatory requirements in the Asia Pacific region
Key Topics
The 5th IFPMA Asian Regulatory Conference will build upon the established forum between regulators and industry to discuss common issues in the regulatory and technical areas in the Asia Pacific region.
ICH and Global Cooperation Group: Developments and support for Asia
Good Regulatory Practices: Are Agencies ready?
Quality: How to ensure Quality of products?
ASEAN Harmonization: Current status and future perspectives
Global Drug Development: Asia role and contribution
Pharmacovigilance & Maintenance of Product Information: How can agencies and industry work together to protect patients?
Future Regulatory Challenges: Is Asia ready?
More than 20 Countries & Regions Covered
Speakers, discussants and participants will be invited from the regulatory authorities of the following countries and regions:
| Australia | Korea | ||
| Bangladesh | Laos | ||
| Brunei Darussalam | Malaysia | ||
| Cambodia | Myanmar | ||
| People's Republic of China | Pakistan | ||
| Chinese Taipei | Philippines | ||
| Chinese Hong Kong | Singapore | ||
| Macau SAR | Sri Lanka | ||
| India | Thailand | ||
| Indonesia | Vietnam | ||
| Japan | |||
A Broad Audience
Regulatory Affairs Professionals, Regulatory Authorities and other Professionals involved in or interested in the pharmaceutical regulatory aspects of ICH and ASEAN harmonization initiatives, Good Regulatory Practices, Quality-GMP, Global Drug Development, Pharmacovigilance in the Asia Pacific region.